Remove 2018 Remove Drug Development Remove healthcare technology Remove Life Science
article thumbnail

AngelEye Health Announces Series B Funding to Support Company’s Rapid Growth

Healthcare IT Today

In the past three years alone, the Company has grown exponentially, more than tripling its annual revenue, growing its employee base to 39, a 5x increase since 2018, and expanding its extensive client list to 125+ partners across the U.S. Within Life Sciences, the firm focuses on MedTech, Diagnostics, and Opportunistic Drug Development.